Live Accenture Plc Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started
Sign up to stay up to date with the stocks you care about
Follow OptiNose, Inc.

Get SEC filing alerts via email and in your feed for OptiNose, Inc.

OPTN

OptiNose, Inc.

About OptiNose, Inc.

Optinose, Inc. is a specialty pharmaceutical company focused on developing and commercializing ENT and allergy treatments. Its flagship product, XHANCE, is a nasal spray utilizing proprietary Exhalation Delivery System technology to deliver corticosteroids deep into nasal passages. The company targets physicians and patients for chronic rhinosinusitis and nasal polyps, emphasizing innovative drug delivery, cost-effective therapies, and expanding into primary care and international markets.
This description was generated via AI from an annual report. Updated 9 months ago.

Latest SEC Filings from OptiNose, Inc.

1
1
2
1
3
1